# Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis

> **NCT02306590** · NA · COMPLETED · sponsor: **University of Ulm** · enrollment: 207 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Calogen
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02306590
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2018-01
- **Final completion:** 2018-09
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306590, "Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02306590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*